 |
Treatment of
prostate cancer.
In 2012, nearly 242,000 people in the United States and other 25,000 are diagnosed with prostate cancer in Canada. The average age at diagnosis is 67 years. Prostate cancer is so common, is the search for treatments that are effective and without side effects, the center of many urologists. To achieve a new treatment for prostate cancer, the results are encouraging and HIFU - or High Intensity Focused Ultrasound.
Localized Prostate Cancer
Prostate cancer is a cancer. The borders of the prostate, is also known as T1 or T2.
T1 is a term used by doctors to be used to describe prostate cancer at an early stage. At this stage, the tumors are small enough to cause signs or symptoms began. T2 is used to describe a cancer that is confined to the prostate, the signs and symptoms began to make it known.
Treatment of prostate cancer by HIFU
Heat Focused Ultrasound HIFU as a means used to destroy cancerous tissue. Focus laser like focus sound waves hit the target tissue and hot. The selection is made with an MRI.
The ultrasonic pulse that destroys tissue from a very small impact area, and only a few cubic millimeters. The affected tissue and multiply, but healthy tissue unharmed beside him.
The rest of the healthy tissue of the prostate after treatment works still able to divide and grow normally. This gives the patient a very good chance of full recovery from cancer.
Day of treatment
HIFU is a non-invasive procedure, which is performed on an outpatient basis. Local and general anesthesia performed. While the patient is on their side, after the anesthetic has taken effect, a rectal probe is inserted into the vicinity of the prostate. MRI of the prostate region, and tumors, which are isolated and aligned.
Collection to segmentation, sending pulses focused ultrasound HIFU device in the tissue affected by cancer. A few mm cube at a time, the diseased tissue is heated at 80 ° C and destroyed. Once heated, the tissue is dead and will not grow. For prostate and lasts 2-4 hours.
Catheter is inserted, in order to treat urinary incontinence patients need to touch for about 2 weeks.
After treatment
when the patient has recovered from the effects of anesthesia, is the home without dietary restrictions and a prescription for antibiotics for a period of two weeks, until the appointment sent tracking.
Side effects of the immediate
experience an inflammation of the prostate may immediately after treatment and a slight leakage. Incontinence can be in addition to the start of urination and the patient slight bleeding feel a strong urge to urinate. These symptoms are temporary and should take about two weeks.
Determination
During the inspection, the catheter is removed, and blood samples were taken to determine the level of PSA. Doctors expect that their PSA levels increased in the first 3-6 months, according to the standardized and stabilized it.
HIFU procedure in Europe for over a decade and has been approved by Health Canada in 2003. It is currently under review by the FDA and approval is expected in 2013. Research data show no effect, a number of safe and effective treatments for localized prostate cancer with fewer side effects than
In 2012, nearly 242,000 people in the United States and other 25,000 are diagnosed with prostate cancer in Canada. The average age at diagnosis is 67 years. Prostate cancer is so common, is the search for treatments that are effective and without side effects, the center of many urologists. To achieve a new treatment for prostate cancer, the results are encouraging and HIFU - or High Intensity Focused Ultrasound.
Localized Prostate Cancer
Prostate cancer is a cancer. The borders of the prostate, is also known as T1 or T2.
T1 is a term used by doctors to be used to describe prostate cancer at an early stage. At this stage, the tumors are small enough to cause signs or symptoms began. T2 is used to describe a cancer that is confined to the prostate, the signs and symptoms began to make it known.
Treatment of prostate cancer by HIFU
Heat Focused Ultrasound HIFU as a means used to destroy cancerous tissue. Focus laser like focus sound waves hit the target tissue and hot. The selection is made with an MRI.
The ultrasonic pulse that destroys tissue from a very small impact area, and only a few cubic millimeters. The affected tissue and multiply, but healthy tissue unharmed beside him.
The rest of the healthy tissue of the prostate after treatment works still able to divide and grow normally. This gives the patient a very good chance of full recovery from cancer.
Day of treatment
HIFU is a non-invasive procedure, which is performed on an outpatient basis. Local and general anesthesia performed. While the patient is on their side, after the anesthetic has taken effect, a rectal probe is inserted into the vicinity of the prostate. MRI of the prostate region, and tumors, which are isolated and aligned.
Collection to segmentation, sending pulses focused ultrasound HIFU device in the tissue affected by cancer. A few mm cube at a time, the diseased tissue is heated at 80 ° C and destroyed. Once heated, the tissue is dead and will not grow. For prostate and lasts 2-4 hours.
Catheter is inserted, in order to treat urinary incontinence patients need to touch for about 2 weeks.
After treatment
when the patient has recovered from the effects of anesthesia, is the home without dietary restrictions and a prescription for antibiotics for a period of two weeks, until the appointment sent tracking.
Side effects of the immediate
experience an inflammation of the prostate may immediately after treatment and a slight leakage. Incontinence can be in addition to the start of urination and the patient slight bleeding feel a strong urge to urinate. These symptoms are temporary and should take about two weeks.
Determination
During the inspection, the catheter is removed, and blood samples were taken to determine the level of PSA. Doctors expect that their PSA levels increased in the first 3-6 months, according to the standardized and stabilized it.
HIFU procedure in Europe for over a decade and has been approved by Health Canada in 2003. It is currently under review by the FDA and approval is expected in 2013. Research data show no effect, a number of safe and effective treatments for localized prostate cancer with fewer side effects than
No comments:
Post a Comment